The report highlights opportunities in pharmaceutical outsourcing through emerging trends, new contracts, M&A activities, and investments in technology. It guides CMOs, pharmaceutical decision-makers, and investors in strategic planning and supplier management by providing insights into regulatory impacts and supply chain developments.
Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, October 2025" report has been added to ResearchAndMarkets.com's offering.
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Report Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more.
This report is required reading for:
CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter's M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Key Topics Covered:
Industry Trends
Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing
Trump Administration Announce Third MFN Agreement, With EMD Serono, and Includes Use of New FDA Voucher
Lower price on fertility treatments
Trump says the price of Ozempic will be lowered
Outlook and implications
Industry Analysis
Contract service agreements
Contract manufacturing - opportunities and threats
Quarterly mergers, acquisitions, and financing - Q3 2025
Value Chain
API chemical
API biologics - cell, gene, vaccine, and virus
API Biologics (Protein and Peptide)
Commercial dose manufacturing and packaging
Analytical services
Companies Featured
Pfizer
Roche
Metsera
Novo Nordisk
Eli Lilly
Genentech
EMD Serono
Sanofi
Achieve Life Sciences
Regeneron
Dompe Farmaceutici
Revolution Medicines
Disc Medicine
Kalvista Pharmaceuticals
Janssen Biotech
Boehringer Ingelheim
AstraZeneca
Travere Therapeutics
Cue Biopharma
OWP Pharmaceuticals
aTyr Pharma
Avyxa Pharma
Acer Therapeutics
Celltrion
TRACON Pharmaceuticals
Calliditas Therapeutics
Jazz Pharmaceuticals
Laboratorios Salvat
OS Therapies
Les Laboratoires Servier
Samsung Biologics
Alteogen
Otsuka Holdings
Teva Pharmaceutical Industries
Vetter Pharma-Fertigung
Wacker Chemie
Zambon
Kincell Bio
Moonlight Bio
OmniaBio
BrainChild Bio
Patheon
Vaxcyte
Pharmaloop
Miltenyi Biotec
Verismo Therapeutics
Lonza
Rion
Wheeler Bio
MindImmune Therapeutics
Matica Biotechnology
LTS Lohmann Therapie-Systeme
Renaissance Lakewood
RoundTable Healthcare Management
Oxford BioMedica
RTP Operating
ROIS Phoenix
Bristol-Myers Squibb
PolyPeptide Group
Axplora Group
Codis
Particle Dynamics
EUROAPI
Piramal Pharma Solutions
ProBioGen
DINAMIQS
SEAL Therapeutics
Cell Therapies
Teijin
Made Scientific
Syenex
IAVI
Minapharm Pharmaceuticals
GC Biopharma
Curevo Vaccine
Rentschler Biopharma
Summit Pharmaceuticals International (SPI)
Celonic Group
CARBOGEN AMCIS
Streamline Bio
Dr. Park CDMO
Thermo Fisher Scientific
Abzena
Revvity
ProteoNic Bioscience
Kindeva Drug Delivery
Polpharma Biologics
Rezon Bio
Symbiosis Pharmaceutical Services
Basilard BioTech
Jubilant HollisterStier
The Ritedose Corp
Praxis Packaging Solutions
Advanced Concept Innovations
Bionique Testing Laboratories
Asahi Kasei
ViruSure
Recipharm
TECHPharm
For more information about this report visit https://www.researchandmarkets.com/r/qvf2yp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900